Argenx USA News and Activities

Argenx USA is owned by Argenx.

Argenx is one of the...

• Forbes Global 2000 (#1953);
• Stoxx 600;
• TOB Iconic 10,000.

Argenx is a company listed under the stock ticker ARGX (BE).

Argenx has a direct presence in 2 countries.

View the org chart displaying its 4 main executives

Most searched biographies at Argenx USA

• Rebecca McLeod, General Manager
• Allen Labrune, Vice President and Head of Patient Support Programs
• Cristian Azcarate, Vice President, Patient Strategy & Experience

Popular executive movements at Argenx

• Judith Scholten, who was Head of Human Resources, Europe, Middle East and Africa, is promoted to Head of Human Resources, Europe, Middle East and Africa and Head of Talent  (posted on April 16 2025).

Create your alert
to follow the executive moves at Argenx USA.

Argenx has 2,339 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Biogen (United States (USA)).

Popular M&A news in Biotechnology

• Regeneron Pharmaceuticals has announced the acquisition of 23andMe  (posted on May 20 2025).
• Stylus Medicine has just announced a $85 Million fundraising (posted on May 16 2025).
• Azafaros has just announced a $132 Million fundraising (posted on May 15 2025).

Popular contacts in Biotechnology

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group
• Deepika Verma - Associate Director of Data Science and Digitalization at Wheeler Bio
• Steven Gillis - Chairman of the Board at VBI Vaccines

Learn more about the Biotechnology industry

Press releases by Argenx USA

Social media about Argenx USA

• Argenx USA on Wikipedia, Google News & Yahoo Finance
• Argenx USA on LinkedIn, Twitter & YouTube